WebJan 19, 2009 · By targeting both Skp2 and Ets2, APC Cdh1 maintains G1 by increasing the levels of a Cdk inhibitor p27 through destabilizing Skp2 and by limiting the expression of cyclin D1 through promoting Ets2 … WebSep 12, 2024 · In response to DNA damage, checkpoint kinase 2 (Chk2) phosphorylates FOXM1 at S361, inhibiting its degradation and increasing transcription of XRCC1 and BRCA2 genes, which are required for repair of DNA damage [ 66 ]. FOXM1 phosphorylation is also linked to ubiquitination and SUMOylation.
Clinicopathological and prognostic significance of CDH1 ...
WebDec 30, 2024 · One HDAC inhibitor, entinostat, showed a strong inhibitory effect on each of the models with CDH1 mutations. This study highlighted the potential beneficial impact of entinostat for the chemoprevention and/or treatment of gastric and breast cancers carrying CDH1 mutations. Abstract WebApr 1, 2011 · Cdc20 and Cdh1 are WD40-containing APC co-activators that bind destruction boxes (DB) and KEN boxes within substrates to recruit them to the APC for ubiquitination. Acm1 is an APC Cdh1 inhibitor that utilizes a DB and a KEN box to bind Cdh1 and prevent substrate binding, although Acm1 itself is not a substrate. We investigated what ... bruce sawhill fbi
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer
WebAbstract. The anaphase-promoting complex (APC) is tightly regulated during cell division, often by pseudosubstrate binding to its coactivators Cdh1 and Cdc20. Budding yeast Acm1 is a Cdh1 pseudosubstrate inhibitor whose biological function is unknown. We show here that cells lacking Acm1 have defects in nuclear positioning and spindle ... WebThe correlation of CDH1 promoter hypermethylation with clinicopathological features. The frequency of CDH1 promoter hypermethylation was significantly higher in HCC than in normal liver tissue; the pooled OR was 4.34 with 95% CI 2.50–7.56, z=5.19, P<0.00001, I 2 =0% (). CDH1 promoter in HCC was more frequently hypermethylated compared to the … WebApr 1, 2024 · E-cadherin defects are frequently found in breast cancer (>13%) and gastric cancer (>14%) and are particularly prevalent in lobular breast cancers, which account for 15% of all mammary carcinomas … ewan archibald